B&K CORP-B Announces Formal Name Change to Qingcheng New Drug Biotechnology

Stock News16:45

An announcement has been issued by B&K CORP-B (ASX: 02396) regarding a formal alteration to its corporate identity.

The company's registered Chinese name has been officially changed from "Huaren Biotechnology (Qingdao) Co., Ltd." to "Qingcheng New Drug Biotechnology (Qingdao) Co., Ltd.".

It is important to note that the company's English name remains completely unchanged.

This change will be implemented in the market starting from 9:00 a.m. on July 22, 2026.

From that time, the Chinese trading abbreviation for the company's shares on the stock exchange will be updated from "Huaren Bio-B" to "Qingcheng New Drug-B".

The English trading abbreviation will continue to be "B&K CORP-B" and the company's stock code will also remain the same at "2396".

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment